| CAS ID: | 119141-88-7 |
| Molecular Formula: | C17H19N3O3S |
| Molecular Weight: | 345.4 g/mol |
| Monoisotopic Mass: | 345.1147 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | ESOMEPRAZOLE STRONTIUM | EMOZUL | H199/18 SODIUM | NEXIUM IV | VENTRA | H199/18 MAGNESIUM TRIHYDRATE | ESOMEPRAZOLE POTASSIUM | ESOMEPRAZOLE | FM0F67 | NEXIUM 24HR | NEXIUM | NEXIUM CONTROL | ESOMEPRAZOLE SODIUM | NEXIUM I.V. | ESOMEPRAZOLE MAGNESIUM |
| Analysis: | Drug repositioning mechanism analysis |
Trial Record 1
| ClinicalTrial ID | NCT01983774 | Disease | Cystic fibrosis |
| Phase | Phase 2 | Status | Terminated |
| First Received | November 14, 2013 | Last Verified | April 14, 2015 |
| Sponsor | Columbia University | ||
| PubChem: | 9568614 |
| ChEMBL: | CHEMBL1201320 |